During the past decade, State Research Center Burnasyan Federal Medical Biophysical Center FMBA of Russia; Center for Biomedical Technologies conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "State Research Center Burnasyan Federal Medical Biophysical Center FMBA of Russia; Center for Biomedical Technologies" #1 sponsor was "Burnasyan Federal Medical Biophysical Center" with 4 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "AO GENERIUM" with 1 trials sponsored, "Abbott" with 1 trials sponsored and "I.M. Sechenov First Moscow State Medical University" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "State Research Center Burnasyan Federal Medical Biophysical Center FMBA of Russia; Center for Biomedical Technologies" #1 collaborator was "Datamap" with 1 trials as a collaborator, "Kuban State Medical University" with 1 trials as a collaborator and "Linical Co., Ltd." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "State Research Center Burnasyan Federal Medical Biophysical Center FMBA of Russia; Center for Biomedical Technologies" are "Rheumatoid Arthritis" (2 trials), "Acute Respiratory Insufficiency" (1 trials), "Acute Respiratory Tract Infection" (1 trials), "Allergy" (1 trials) and "Alzheimer's Disease" (1 trials). Many other conditions were trialed in "State Research Center Burnasyan Federal Medical Biophysical Center FMBA of Russia; Center for Biomedical Technologies" in a lesser frequency.

Most popular intervention types in "State Research Center Burnasyan Federal Medical Biophysical Center FMBA of Russia; Center for Biomedical Technologies" are "Drug" (5 trials), "Other" (2 trials), "Procedure" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Berinert®, 20 МЕ/ kg" (1 trials), "DMARDs (disease-modifying antirheumatic drugs)" (1 trials), "GNR-038, 100 МЕ/ kg" (1 trials) and "GNR-038, 50 МЕ/ kg" (1 trials). Other intervention names were less common.

The vast majority of trials in "State Research Center Burnasyan Federal Medical Biophysical Center FMBA of Russia; Center for Biomedical Technologies" are 8 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "State Research Center Burnasyan Federal Medical Biophysical Center FMBA of Russia; Center for Biomedical Technologies". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in State Research Center Burnasyan Federal Medical Biophysical Center FMBA of Russia; Center for Biomedical Technologies, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in State Research Center Burnasyan Federal Medical Biophysical Center FMBA of Russia; Center for Biomedical Technologies, 2 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".